Avadel's US Application In Sleep Disorder Accepted For Review Home > Business > Article
3 years ago By Hernandez — The FDA has accepted Avadel Pharmaceuticals Plc's (NASDAQ: AVDL) marketing application seeking approval for FT218 for review. FT218 is a formulation to tre
#avadel #usapplication #sleep